AI for pollution-related lung disease detection
Part of Cancer, Lungs & breathing clinical trials.
This study uses artificial intelligence to analyze lung images and breathing tests from people with COPD, asthma, or lung cancer to better understand how pollution affects the lungs. It may help find new ways to detect these diseases earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with COPD, asthma, lung cancer, or other lung/chest conditions that might be linked to pollution.
- You need to live in Timis county in Romania and have a stable home address.
- For the second part of the study, you need a special type of CT scan (HRCT) of your lungs taken within a specific time frame.
- You must not have had any lung surgery in the past.
- You must not have allergies to contrast dye (used in some CT scans).
- You need to have had a breathing test (spirometry) and possibly a lung gas exchange test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to analyze CT scans and other health data to better identify people at risk for smoking-related diseases like lung cancer. Researchers hope to improve early detection and prevention.
This trial uses artificial intelligence (AI) to help doctors read X-rays or CT scans of people with respiratory infections. The goal is to see if AI can make diagnosis faster and more accurate.
This study tests how well an AI tool can predict lung cancer risk, based on your health information. It looks at how patients feel about this approach to screening, with the goal of making screening more personal and effective.
This trial uses artificial intelligence to improve low-dose CT scans for early lung cancer detection. If you are at higher risk due to smoking or family history, or just want a routine check, you may be able to join.
This study tests whether an AI tool can correctly find lung scarring (pulmonary fibrosis) on CT scans as well as doctors do. The results could lead to faster, more consistent detection of this condition.
This trial tests whether using AI to help radiologists read lung CT scans can find cancer earlier and lower healthcare costs. You may qualify if you are at risk for lung cancer and have not been screened recently.
Hear when a new Emphysema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.